The Department fully understands that maintaining access to hormone replacement therapy (HRT) medications is vitally important to many people in this country.
The Department has well established processes to manage and mitigate the small number of supply problems that may arise at any one time.
We are aware of ongoing supply issues with some HRT preparations due to manufacturing delays. We have been working closely with all suppliers of HRT medicines to maintain overall supply to patients and we have provided regular updates about the supply situation including clinical guidance to the National Health Service.
We will continue to work with affected suppliers to resolve the supply issues as soon as possible and to ensure supplies of HRT products continue to remain available.